申请人:Eli Lilly and Company
公开号:US06617351B1
公开(公告)日:2003-09-09
The present invention provides certain amide, carbamate and urea derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.
本发明提供了一些酰胺、碳酸酯和脲衍生物,用于增强哺乳动物中谷氨酸受体的功能,因此,用于治疗各种疾病,如精神疾病和神经系统疾病。